Amanote Research
Register
Sign In
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
- Greece
doi 10.3892/ijmm.2011.814
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Genetics
Date
October 13, 2011
Authors
Tak Chan
Publisher
Spandidos Publications
Related search
Curcumin in Combination With Bortezomib Synergistically Induced Apoptosis in Human Multiple Myeloma U266 Cells
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance
Blood Cancer Journal
Oncology
Hematology
Novel Strategies to Target the Ubiquitin Proteasome System in Multiple Myeloma
Oncotarget
Oncology
Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy
Sensors
Instrumentation
Information Systems
Electronic Engineering
Biochemistry
Analytical Chemistry
Molecular Physics,
Electrical
Atomic
Medicine
Optics
Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy
Journal of Cell Science & Therapy
Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
PLoS ONE
Multidisciplinary
Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
Cancer Cell
Cancer Research
Oncology
Cell Biology
Signaling Mechanisms of Bortezomib in TRAF3-deficient Mouse B Lymphoma and Human Multiple Myeloma Cells
Leukemia Research
Cancer Research
Oncology
Hematology